Sight Diagnostics Stock

Sight Diagnostics is an Israeli medical devices startup that’s using AI technology to speed up blood testing. Its mission is to change the way blood testing is done by providing fast, convenient and accurate diagnostics in a compact platform designed for use in any clinical setting, overseen by CLIA certified lab. Developed over almost a decade of research, its technology combines the latest innovations in blood sample preparation, optics, chemistry, biology, physics and computer science. Its first product, Parasight™, has diagnosed malaria in nearly 1 million tests across 24 countries. Sight OLO®, their latest blood analyzer, digitizes blood with only 2 drops of a finger prick or venous sample and provides lab-grade CBC results in minutes.